Literature DB >> 28749920

Announcement: Monitoring Selected National HIV Prevention and Care Objectives.

.   

Abstract

CDC monitors progress on selected national human immunodeficiency virus (HIV) prevention and care objectives using surveillance data (1) and has released two HIV care continuums for 2014: a diagnosis-based continuum and a prevalence-based continuum (2,3).

Entities:  

Mesh:

Year:  2017        PMID: 28749920      PMCID: PMC5657813          DOI: 10.15585/mmwr.mm6629a6

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


CDC monitors progress on selected national human immunodeficiency virus (HIV) prevention and care objectives using surveillance data () and has released two HIV care continuums for 2014: a diagnosis-based continuum and a prevalence-based continuum (,). A diagnosis-based HIV continuum monitors key steps needed for a person living with diagnosed HIV infection to reach viral suppression, which leads to improved health outcomes and reduced risk for transmission to others. To determine a diagnosis-based HIV continuum, CDC uses the number of persons living with diagnosed HIV infection as the denominator. CDC monitors engagement in medical care and viral suppression in 38 jurisdictions that have complete reporting of CD4 and viral load laboratory results. Among persons living with diagnosed HIV infection at year-end 2014 in 38 jurisdictions, 73% received HIV medical care in 2014, 57% were retained in continuous care, and 58% were virally suppressed (). Because the first step in entering HIV care is receiving a diagnosis, CDC has also estimated an HIV prevalence-based continuum, which uses the estimated number of all persons living with diagnosed or undiagnosed HIV infection as the denominator. Among the estimated 1.1 million persons living with HIV infection in the United States in 2014, 85% had received a diagnosis (). Extrapolating from 38 jurisdictions with complete reporting, an estimated 62% of persons living with HIV infection received HIV medical care in 2014, 48% were retained in continuous care, and 49% were virally suppressed (). More information is available in the Division of HIV/AIDS Prevention report and accompanying fact sheet and slide set (–).
  3 in total

Review 1.  Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States.

Authors:  Mary Clare Masters; Karen M Krueger; Janna L Williams; Lindsay Morrison; Susan E Cohn
Journal:  Expert Rev Clin Pharmacol       Date:  2019-12       Impact factor: 5.045

2.  Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study.

Authors:  Yunxuan Huang; Oulu Zhou; Zhigang Zheng; Yuexiang Xu; Yi Shao; Chunwei Qin; Fengxiang Qin; Jingzhen Lai; Huifang Liu; Rongfeng Chen; Li Ye; Hao Liang; Xionglin Qin; Junjun Jiang
Journal:  AIDS Res Ther       Date:  2020-07-17       Impact factor: 2.250

3.  Significance of Increased Rapid Treatment from HIV Diagnosis to the First Antiretroviral Therapy in the Recent 20 Years and Its Implications: the Korea HIV/AIDS Cohort Study.

Authors:  Yoon Jung Kim; Shin Woo Kim; Ki Tae Kwon; Hyun Ha Chang; Sang Il Kim; Youn Jeong Kim; Min Ja Kim; Jun Yong Choi; Hyo Youl Kim; June Myung Kim; Bo Youl Choi; Bo Young Park; Yun Su Choi; Mee Kyung Kee; Myeong Su Yoo; Jung Gyu Lee
Journal:  J Korean Med Sci       Date:  2019-10-07       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.